Oncology · Adenocarcinoma of the Esophagus and Esophagogastric Junction

Adenocarcinoma of the Esophagus and EGJ: Your Complete Guide

At a Glance

Esophageal and EGJ adenocarcinoma treatments are advancing rapidly. This guide helps patients navigate their diagnosis, understand pathology and biomarkers, explore treatment options like FLOT chemotherapy, and manage survivorship with a multidisciplinary team.

Receiving a diagnosis of esophageal adenocarcinoma (EAC) or esophagogastric junction (EGJ) adenocarcinoma is a life-altering event. This guide is designed to help you, and your loved ones navigate the days, months, and years ahead with clarity and confidence.

The most important thing to know is that you are entering an era of rapid medical advancement. Because this specific type of cancer is becoming more common, clinical trials and research have exploded. The treatments available today are more precise, highly personalized, and more effective than ever before ^[1]^[2].

Note: This resource is specifically for Adenocarcinoma. If you have been diagnosed with Esophageal Squamous Cell Carcinoma (ESCC), your risk factors, biology, and treatment pathways will be different.

How to Use This Guide

We have broken down the complex medical journey into focused sections. We recommend starting with the overview and then moving through the topics that match where you currently are in your treatment timeline.

Validation & Orientation: Understanding Your Diagnosis

Learn about your esophageal adenocarcinoma (EAC) or esophagogastric junction (EGJ) diagnosis. Understand causes, symptoms, and the role of multimodal therapy.

Symptoms & Risk Factors: Why Did This Happen?

Learn the symptoms and risk factors for esophageal adenocarcinoma (EAC). Understand the role of Barrett's esophagus, visceral obesity, and silent reflux.

Diagnosis & Staging: Mapping the Cancer

Learn how esophageal and EGJ adenocarcinoma is diagnosed and staged. Understand EUS, PET/CT scans, and what your Siewert Classification means for surgery.

Pathology & Biomarkers: Decoding Your Report

Learn how to read your esophageal adenocarcinoma pathology report. Understand TNM staging, PD-L1 CPS scores, HER2, and CLDN18.2 for personalized treatment.

Treatment Strategy: Early and Localized Disease

Learn about treatment options for early and localized esophageal adenocarcinoma (EAC). Understand endoscopic procedures, the FLOT regimen, and what to expect.

Treatment Strategy: Advanced and Metastatic Disease

Learn about treatment options for advanced esophageal and EGJ adenocarcinoma. Understand how biomarkers like HER2, PD-L1, and CLDN18.2 guide your therapy.

Survivorship & Quality of Life: Life After Treatment

Learn how to navigate life after esophageal and EGJ cancer treatment. Understand dietary changes, dumping syndrome, surveillance schedules, and scanxiety.

Your medical team has the expertise, but you are the captain of your care. Use the questions provided at the top of each page to start informed, empowering conversations with your doctors.

Common questions in this guide

How do I know if my tumor is an adenocarcinoma or squamous cell carcinoma?

Your pathology report will specify your exact cancer type based on a biopsy of the tumor. It is important to confirm this with your doctor, as adenocarcinomas and squamous cell carcinomas have very different risk factors, biology, and treatment pathways.

What is the esophagogastric junction (EGJ)?

The esophagogastric junction, or EGJ, is the specific anatomical area where your esophagus connects to your stomach. Cancers in this area require precise staging and specialized surgical planning to ensure the best possible outcome.

Why is a multidisciplinary team important for my care?

Esophageal cancer care is highly complex and requires experts from multiple medical fields, including medical oncology, surgical oncology, and gastroenterology. A multidisciplinary team ensures all aspects of your treatment are coordinated and personalized to your specific tumor.

What are the risk factors for developing esophageal adenocarcinoma?

Key metabolic and biological risk factors include Barrett's esophagus, visceral obesity, and metabolic syndrome. These conditions can cause chronic changes in the lining of the lower esophagus that may eventually lead to adenocarcinoma.

Curated prompts to bring to your next appointment.

1.Can you confirm whether my tumor is an adenocarcinoma or squamous cell carcinoma?
2.Who is the main point of contact on my multidisciplinary team for urgent questions?
3.Can you explain the overall timeline of my treatment plan, from today through recovery?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (2)

1
Increasing Use of PET-CT, Neoadjuvant Treatment, Minimally Invasive Approach and Surgical Radicality in Esophageal Cancer Surgery are Associated with Improved Short- and Long-term Outcomes in Real-World Setting.
Junttila A, Saviaro H, Huhta H, et al.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2022; (26(4)):742-749 doi:10.1007/s11605-022-05279-z.
PMID: 35217930
2
Etiologic factors for Barrett's esophagus: toward countermeasures in Asia.
Iijima K
Expert review of gastroenterology & hepatology 2024; (18(8)):407-420 doi:10.1080/17474124.2024.2386367.
PMID: 39072626

This guide is for informational purposes only and does not replace professional medical advice. Always consult your oncology team about your specific esophageal or EGJ cancer diagnosis and treatment plan.

Get notified when new evidence is published on Adenocarcinoma of the oesophagus and oesophagogastric junction.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents